Please use this identifier to cite or link to this item: https://hdl.handle.net/10923/18312
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGONÇALVES, MARCUS VINÍCIUS MAGNO-
dc.contributor.authorBRANDÃO, WESLEY NOGUEIRA-
dc.contributor.authorLONGO, CARLA-
dc.contributor.authorSCHATZMANN, JEAN PIERRE-
dc.contributor.authorDOS PASSOS, GIORDANI RODRIGUES-
dc.contributor.authorPAGLIARINI, GABRIELA LÖW-
dc.contributor.authorDO NASCIMENTO, OSVALDO JOSE MOREIRA-
dc.contributor.authorDaniel Rodrigo Marinowic-
dc.contributor.authorMachado, Denise Cantarelli-
dc.contributor.authorBECKER, JEFFERSON-
dc.date.accessioned2021-09-15T12:23:11Z-
dc.date.available2021-09-15T12:23:11Z-
dc.date.issued2020-
dc.identifier.issn0165-5728-
dc.identifier.urihttps://hdl.handle.net/10923/18312-
dc.language.isoen-
dc.relation.ispartofJOURNAL OF NEUROIMMUNOLOGY-
dc.rightsopenAccess-
dc.titleCorrelation between IL-31 and sCD40L plasma levels in Fingolimod-treated patients with Relapsing-Remitting Multiple Sclerosis (RRMS)-
dc.typeArticle-
dc.date.updated2021-09-15T12:23:10Z-
dc.identifier.doiDOI:10.1016/j.jneuroim.2020.577435-
dc.jtitleJOURNAL OF NEUROIMMUNOLOGY-
dc.volume350-
dc.spage577435-
dc.epage577-
Appears in Collections:Artigo de Periódico



All Items in PUCRS Repository are protected by copyright, with all rights reserved, and are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Read more.